Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-08-16 00:00:00 ET · period of report 2023-08-14 · accession 0001674236-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-16 | 2023-08-14 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale | $61.37 | -17.6K | 155.8K | -10% | -$1.08M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-14 | S | D | 17,639 | $61.37 | 155,839 | D | — | — | (F1) Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.50 to $61.86, inclusive. |